Vistagen Therapeutics (VTGN) Sale and Maturity of Investments (2024 - 2026)
Vistagen Therapeutics' Sale and Maturity of Investments - Total was $6.68 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 233.8% from $2 million a year earlier and up 19.2% from the prior quarter.
Vistagen Therapeutics (VTGN) Sale and Maturity of Investments (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vistagen Therapeutics' Sale and Maturity of Investments - Total was $23.85 million through Sep 30, 2026, up 44.3% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $21.58 million, up 79.4% from FY2025.
- In earlier fiscal years, Sale and Maturity of Investments - Total was $12.03 million in FY2025.
- The fiscal Q2 2027 figure marks the highest quarterly Sale and Maturity of Investments - Total since fiscal Q1 2026.
- Compared with a year earlier, Sale and Maturity of Investments - Total was higher in three of the last five quarters, with growth averaging 72.7%.
- Per Business Quant data, VTGN's Sale and Maturity of Investments - Total in the three fiscal quarters before Q2 2027 was $5.6 million (Q1 2027), $5.58 million (Q4 2026) and $6 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | - |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | - |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 308.00 Mn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | - |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 405.00 Mn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | 88.00 Mn |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | - |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | 6.68 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.68 Mn |
| Jun 30, 2026 | 5.60 Mn |
| Mar 31, 2026 | 5.58 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 5.50 Mn |
Vistagen Therapeutics Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();